CoralOghenerukevweOmeneMDPhD
Oncology • New Brunswick, NJBreast Cancer, Hematologic Oncology
Program Director, Breast Cancer Disparities Research; Associate Professor of Medicine; Rutgers Cancer Institute; Division of Medical Oncology; Rutgers, The State University of New Jersey
Dr. Omene is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St.
New Brunswick, NJ 08903Phone+1 732-235-9692Fax+1 732-235-7943
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
NJ State Medical License 2017 - 2025
NY State Medical License 2005 - 2017- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases Start of enrollment: 2011 Aug 19
Publications & Presentations
PubMed
- 567 citationsSacituzumab Govitecan in Metastatic Triple-Negative Breast CancerAditya Bardia, Sara A. Hurvitz, Sara M Tolaney, Delphine Loirat, Kevin Punie
The New England Journal of Medicine. 2021-04-21 - 73 citationsClinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer.Mridula George, Sadaf Qureshi, Coral Omene, Deborah Toppmeyer, Shridar Ganesan
Frontiers in Oncology. 2021-07-12 - 4 citationsAssociation of Cigarette Smoking and Alcohol Consumption With Subsequent Mortality Among Black Breast Cancer Survivors in New Jersey.Nur Zeinomar, Bo Qin, Saber Amin, Yong Lin, Baichen Xu
JAMA Network Open. 2023-01-03
Grant Support
- Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)NIH/NCIPresent
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
